Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: Pooled analysis in 4 basque country university hospitals
- del Prado, P.M.
- Alvarez-López, I.
- Domínguez-Fernández, S.
- Plazaola, A.
- Ibarrondo, O.
- Galve-Calvo, E.
- Ancizar-Lizarraga, N.
- Gutierrez-Toribio, M.
- Lahuerta-Martínez, A.
- Mar, J.
Zeitschrift:
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
Datum der Publikation: 2018
Ausgabe: 10
Seiten: 189-199
Art: Artikel
